The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages

被引:810
作者
Allavena, Paola [1 ]
Sica, Antonio [1 ,2 ]
Solinas, Graziella [1 ]
Porta, Chiara [1 ]
Mantovani, Alberto [1 ,3 ]
机构
[1] IRCCS Ist Clin Humanitas, Milan 20089, Italy
[2] Fdn Humanitas Ric, Milan 20089, Italy
[3] State Univ Milan, Inst Pathol, Milan 20133, Italy
关键词
tumor-associated macrophages (TAM); inflammation; tumor; cytokines; chemokines; angiogenesis; matrix-metallo proteases (MMP); micro-environment;
D O I
10.1016/j.critrevonc.2007.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The link between inflammation and cancer proposed more than a century ago by Rudolf Virchow, who noticed the infiltration of leukocytes in malignant tissues, has recently found a number of genetic and molecular confirmations. Experimental, clinical and epidemiological studies have revealed that chronic inflammation contributes to cancer progression and even predisposes to different types of cancer. Cancer-associated inflammation includes: the presence of leukocyte infiltration; the expression of cytokines such as tumor necrosis factor (TNF) or interleukin (IL)-1; chemokines such as CCL2 and CXCL8; active tissue remodelling and neo-angiogenesis. Tumor-associated macrophages (TAM) are key regulators of the link between inflammation and cancer. Many observations indicate that, in the tumor micro-environment, TAM have several protumoral functions, including expression of growth factors, matrix proteases, promotion of angiogenesis and suppression of adaptive immunity. In this review we will discuss the role of TAM in the inflammatory micro-environment of solid tumors and will try to identify potential target for future therapeutic approaches. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 95 条
  • [1] A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells
    Adema, GJ
    Hartgers, F
    Verstraten, R
    deVries, E
    Marland, G
    Menon, S
    Foster, J
    Xu, YM
    Nooyen, P
    McClanahan, T
    Bacon, KB
    Figdor, CG
    [J]. NATURE, 1997, 387 (6634) : 713 - 717
  • [2] Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
    Allavena, P
    Signorelli, M
    Chieppa, M
    Erba, E
    Bianchi, G
    Marchesi, F
    Olimpio, CO
    Bonardi, C
    Garbi, A
    Lissoni, A
    de Brand, F
    Jimeno, J
    D'Incalci, M
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2964 - 2971
  • [3] Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
  • [4] 2-4
  • [5] AN T, 1987, AM J PATHOL, V128, P52
  • [6] Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
    Arenberg, DA
    Keane, MP
    DiGiovine, B
    Kunkel, SL
    Strom, SRB
    Burdick, MD
    Iannettoni, MD
    Strieter, RM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (02) : 63 - 70
  • [7] Bachelder RE, 2002, CANCER RES, V62, P7203
  • [8] Cancer and the chemokine network
    Balkwill, F
    [J]. NATURE REVIEWS CANCER, 2004, 4 (07) : 540 - 550
  • [9] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [10] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545